TCL Archive In Brief: Columbia’s Marks Reportedly Will Move To MSK; FDA Committee to Consider THC For Group C List May 23, 1980
TCL Archive Gynecologic Oncology Group To Conduct Phase III Trial of Xyotax For Ovarian Cancer April 30, 2004
TCL Archive Turnover In Immunology Contracts To Free Up Substantial Sums, Possible New RFPs Listed October 8, 1976
TCL Archive Anastrozole Better Than Tamoxifen For HR+ Postmenopausal Breast Cancer, Study Finds May 27, 2005
